$QURE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in uniQure N.V..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in uniQure N.V.. Get notifications about new insider transactions in uniQure N.V. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2019 | QURE | uniQure N.V. | Gut Robert | Chief Medical Offic ... | Grant | A | 0.00 | 5,147 | 0 | 40,147 | 35 K to 40.1 K (+14.71 %) |
Jan 29 2019 | QURE | uniQure N.V. | Balachandran Madhavan | Director | Option Exercise | A | 31.71 | 5,295 | 167,904 | 5,295 | |
Jan 29 2019 | QURE | uniQure N.V. | Balachandran Madhavan | Director | Grant | A | 0.00 | 3,230 | 0 | 8,022 | 4.8 K to 8 K (+67.40 %) |
Jan 29 2019 | QURE | uniQure N.V. | Astley-Sparke Philip | Director | Option Exercise | A | 31.71 | 5,295 | 167,904 | 5,295 | |
Jan 29 2019 | QURE | uniQure N.V. | Astley-Sparke Philip | Director | Grant | A | 0.00 | 3,230 | 0 | 26,482 | 23.3 K to 26.5 K (+13.89 %) |
Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Option Exercise | A | 31.71 | 18,325 | 581,086 | 18,325 | |
Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Grant | A | 0.00 | 10,913 | 0 | 41,571 | 30.7 K to 41.6 K (+35.60 %) |
Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Grant | A | 0.00 | 5,589 | 0 | 30,658 | 25.1 K to 30.7 K (+22.29 %) |
Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Option Exercise | A | 31.71 | 18,325 | 581,086 | 18,325 | |
Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Grant | A | 0.00 | 10,913 | 0 | 41,571 | 30.7 K to 41.6 K (+35.60 %) |
Jan 29 2019 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Grant | A | 0.00 | 5,589 | 0 | 30,658 | 25.1 K to 30.7 K (+22.29 %) |
Jan 07 2019 | QURE | uniQure N.V. | KLEMT CHRISTIAN | Chief Accounting Of ... | Sell | S | 27.91 | 5,739 | 160,175 | 40,000 | 45.7 K to 40 K (-12.55 %) |
Dec 06 2018 | QURE | uniQure N.V. | Astley-Sparke Philip | Director | Sell | S | 30.39 | 5,000 | 151,950 | 23,252 | 28.3 K to 23.3 K (-17.70 %) |
Sep 25 2018 | QURE | uniQure N.V. | Gut Robert | Chief Medical Offic ... | Option Exercise | A | 39.97 | 70,000 | 2,797,900 | 70,000 | |
Sep 25 2018 | QURE | uniQure N.V. | Gut Robert | Chief Medical Offic ... | Grant | A | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
Jun 18 2018 | QURE | uniQure N.V. | Gut Robert | Director | Option Exercise | A | 35.40 | 10,000 | 354,000 | 10,000 | |
Jun 18 2018 | QURE | uniQure N.V. | Gut Robert | Director | Option Exercise | A | 35.40 | 10,000 | 354,000 | 10,000 | |
Jun 18 2018 | QURE | uniQure N.V. | Meek David D. | Director | Option Exercise | A | 35.40 | 10,000 | 354,000 | 10,000 | |
Jun 08 2018 | QURE | uniQure N.V. | Zelenkofske Steven | Chief Medical Offic ... | Sell | S | 37.14 | 23,929 | 888,723 | 159,458 | 183.4 K to 159.5 K (-13.05 %) |
Mar 19 2018 | QURE | uniQure N.V. | Kapusta Matthew C | CEO, CFO, Managing ... | Sell | S | 21.72 | 39,169 | 850,751 | 439,764 | 478.9 K to 439.8 K (-8.18 %) |
Jan 31 2018 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 18.53 | 2,878 | 53,329 | 17,914 | 20.8 K to 17.9 K (-13.84 %) |
Jan 31 2018 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Sell | S | 18.53 | 5,985 | 110,902 | 25,069 | 31.1 K to 25.1 K (-19.27 %) |
Jan 31 2018 | QURE | uniQure N.V. | Astley-Sparke Philip | Director | Sell | S | 18.53 | 6,540 | 121,186 | 28,252 | 34.8 K to 28.3 K (-18.80 %) |
Jan 31 2018 | QURE | uniQure N.V. | Kaye Jack | Director | Sell | S | 18.53 | 2,878 | 53,329 | 12,914 | 15.8 K to 12.9 K (-18.22 %) |
Jan 31 2018 | QURE | uniQure N.V. | SCHAFFER DAVID | Director | Sell | S | 18.53 | 2,878 | 53,329 | 15,314 | 18.2 K to 15.3 K (-15.82 %) |
Jan 30 2018 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Option Exercise | A | 19.39 | 20,788 | 403,079 | 20,788 | |
Jan 30 2018 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Grant | A | 0.00 | 7,795 | 0 | 31,054 | 23.3 K to 31.1 K (+33.51 %) |
Jan 30 2018 | QURE | uniQure N.V. | Zelenkofske Steven | Chief Medical Offic ... | Option Exercise | A | 19.39 | 22,364 | 433,638 | 22,364 | |
Jan 30 2018 | QURE | uniQure N.V. | Zelenkofske Steven | Chief Medical Offic ... | Grant | A | 0.00 | 8,387 | 0 | 183,387 | 175 K to 183.4 K (+4.79 %) |
Jan 30 2018 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Option Exercise | A | 19.39 | 6,390 | 123,902 | 6,390 | |
Jan 30 2018 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Grant | A | 0.00 | 4,792 | 0 | 4,792 | 0 to 4.8 K |
Jan 30 2018 | QURE | uniQure N.V. | McMillan Scott T. | Chief Operating Off ... | Option Exercise | A | 19.39 | 13,419 | 260,194 | 13,419 | |
Jan 30 2018 | QURE | uniQure N.V. | McMillan Scott T. | Chief Operating Off ... | Grant | A | 0.00 | 5,032 | 0 | 5,032 | 0 to 5 K |
Jan 30 2018 | QURE | uniQure N.V. | KLEMT CHRISTIAN | Chief Accounting Of ... | Option Exercise | A | 19.39 | 22,620 | 438,602 | 22,620 | |
Jan 30 2018 | QURE | uniQure N.V. | KLEMT CHRISTIAN | Chief Accounting Of ... | Grant | A | 0.00 | 8,482 | 0 | 45,739 | 37.3 K to 45.7 K (+22.77 %) |
Jan 30 2018 | QURE | uniQure N.V. | Kapusta Matthew C | CEO, CFO, Managing ... | Option Exercise | A | 19.39 | 83,663 | 1,622,226 | 83,663 | |
Jan 30 2018 | QURE | uniQure N.V. | Kapusta Matthew C | CEO, CFO, Managing ... | Grant | A | 0.00 | 31,374 | 0 | 478,933 | 447.6 K to 478.9 K (+7.01 %) |
Jan 30 2018 | QURE | uniQure N.V. | Garen Jonathan | Chief Business Offi ... | Option Exercise | A | 19.39 | 22,364 | 433,638 | 22,364 | |
Jan 30 2018 | QURE | uniQure N.V. | Garen Jonathan | Chief Business Offi ... | Grant | A | 0.00 | 8,387 | 0 | 93,638 | 85.3 K to 93.6 K (+9.84 %) |
Jan 30 2018 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Option Exercise | A | 19.39 | 22,843 | 442,926 | 22,843 | |
Jan 30 2018 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Grant | A | 0.00 | 8,566 | 0 | 93,817 | 85.3 K to 93.8 K (+10.05 %) |
Jan 30 2018 | QURE | uniQure N.V. | Cantor Maria E | SVP, Investor Rel. ... | Option Exercise | A | 19.39 | 19,169 | 371,687 | 19,169 | |
Jan 30 2018 | QURE | uniQure N.V. | Cantor Maria E | SVP, Investor Rel. ... | Grant | A | 0.00 | 7,188 | 0 | 92,439 | 85.3 K to 92.4 K (+8.43 %) |
Jan 30 2018 | QURE | uniQure N.V. | Balachandran Madhavan | Director | Option Exercise | A | 19.39 | 6,390 | 123,902 | 6,390 | |
Jan 30 2018 | QURE | uniQure N.V. | Balachandran Madhavan | Director | Grant | A | 0.00 | 4,792 | 0 | 4,792 | 0 to 4.8 K |
Jan 30 2018 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Option Exercise | A | 19.39 | 6,390 | 123,902 | 6,390 | |
Jan 30 2018 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Grant | A | 0.00 | 4,792 | 0 | 20,792 | 16 K to 20.8 K (+29.95 %) |
Jan 30 2018 | QURE | uniQure N.V. | SCHAFFER DAVID | Director | Option Exercise | A | 19.39 | 6,390 | 123,902 | 6,390 | |
Jan 30 2018 | QURE | uniQure N.V. | SCHAFFER DAVID | Director | Grant | A | 0.00 | 4,792 | 0 | 18,192 | 13.4 K to 18.2 K (+35.76 %) |
Jan 30 2018 | QURE | uniQure N.V. | Kuta Alexander Edward III | SVP, Regulatory Aff ... | Option Exercise | A | 19.39 | 23,962 | 464,623 | 23,962 | |
Jan 30 2018 | QURE | uniQure N.V. | Kuta Alexander Edward III | SVP, Regulatory Aff ... | Grant | A | 0.00 | 8,986 | 0 | 8,986 | 0 to 9 K |
Jan 30 2018 | QURE | uniQure N.V. | Kaye Jack | Director | Option Exercise | A | 19.39 | 6,390 | 123,902 | 6,390 | |
Jan 30 2018 | QURE | uniQure N.V. | Kaye Jack | Director | Grant | A | 0.00 | 4,792 | 0 | 15,792 | 11 K to 15.8 K (+43.56 %) |
Jan 30 2018 | QURE | uniQure N.V. | Astley-Sparke Philip | Director | Option Exercise | A | 19.39 | 6,390 | 123,902 | 6,390 | |
Jan 30 2018 | QURE | uniQure N.V. | Astley-Sparke Philip | Director | Grant | A | 0.00 | 4,792 | 0 | 34,792 | 30 K to 34.8 K (+15.97 %) |
Jan 05 2018 | QURE | uniQure N.V. | KLEMT CHRISTIAN | Chief Accounting Of ... | Sell | S | 20.13 | 5,093 | 102,510 | 37,257 | 42.4 K to 37.3 K (-12.03 %) |
Jan 05 2018 | QURE | uniQure N.V. | Kapusta Matthew C | CEO, CFO, Managing ... | Sell | S | 19.87 | 21,690 | 431,069 | 447,559 | 469.2 K to 447.6 K (-4.62 %) |
Dec 15 2017 | QURE | uniQure N.V. | KLEMT CHRISTIAN | Chief Accounting Of ... | Grant | A | 0.00 | 19,350 | 0 | 42,350 | 23 K to 42.4 K (+84.13 %) |
Dec 15 2017 | QURE | uniQure N.V. | Kapusta Matthew C | CEO, CFO, Managing ... | Grant | A | 0.00 | 61,560 | 0 | 271,185 | 209.6 K to 271.2 K (+29.37 %) |
Dec 15 2017 | QURE | uniQure N.V. | Kapusta Matthew C | CEO, CFO, Managing ... | Grant | A | 0.00 | 209,625 | 0 | 209,625 | 0 to 209.6 K |
Dec 15 2017 | QURE | uniQure N.V. | Garen Jonathan | Chief Business Offi ... | Grant | A | 0.00 | 56,115 | 0 | 56,115 | 0 to 56.1 K |
Dec 15 2017 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Grant | A | 0.00 | 56,115 | 0 | 56,115 | 0 to 56.1 K |
Dec 15 2017 | QURE | uniQure N.V. | Cantor Maria E | SVP, Investor Relat ... | Grant | A | 0.00 | 56,115 | 0 | 56,115 | 0 to 56.1 K |
Sep 26 2017 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Option Exercise | A | 8.49 | 10,000 | 84,900 | 10,000 | |
Sep 22 2017 | QURE | uniQure N.V. | Balachandran Madhavan | Director | Option Exercise | A | 8.49 | 10,000 | 84,900 | 10,000 | |
Sep 22 2017 | QURE | uniQure N.V. | van Deventer Sander | Chief Scientific Of ... | Option Exercise | A | 8.49 | 150,000 | 1,273,500 | 150,000 | |
Sep 22 2017 | QURE | uniQure N.V. | McMillan Scott T. | Chief Operating Off ... | Option Exercise | A | 8.49 | 150,000 | 1,273,500 | 150,000 | |
Jun 29 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Option Exercise | M | 3.50 | 21,547 | 75,430 | 0 | |
Jun 29 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Option Exercise | M | 3.49 | 27,753 | 96,933 | 21,547 | |
Jun 29 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Sell | S | 6.02 | 21,547 | 129,709 | 0 | 21.5 K to 0 (-100.00 %) |
Jun 29 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Buy | M | 3.50 | 21,547 | 75,430 | 21,547 | 0 to 21.5 K |
Jun 29 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Sell | S | 6.01 | 27,753 | 166,859 | 0 | 27.8 K to 0 (-100.00 %) |
Jun 29 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Buy | M | 3.49 | 27,753 | 96,933 | 27,753 | 0 to 27.8 K |
Jun 28 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Option Exercise | M | 3.48 | 7,700 | 26,804 | 49,300 | |
Jun 28 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Option Exercise | M | 3.43 | 58,075 | 199,366 | 57,000 | |
Jun 28 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Option Exercise | M | 3.42 | 155 | 531 | 115,075 | |
Jun 28 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Sell | S | 6.00 | 7,700 | 46,215 | 0 | 7.7 K to 0 (-100.00 %) |
Jun 28 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Buy | M | 3.48 | 7,700 | 26,804 | 7,700 | 0 to 7.7 K |
Jun 28 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Sell | S | 6.01 | 58,075 | 349,054 | 0 | 58.1 K to 0 (-100.00 %) |
Jun 28 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Buy | M | 3.43 | 58,075 | 199,366 | 58,075 | 0 to 58.1 K |
Jun 28 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Sell | S | 6.00 | 155 | 930 | 0 | 155 to 0 (-100.00 %) |
Jun 28 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Buy | M | 3.42 | 155 | 531 | 155 | 0 to 155 |
Jun 08 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Option Exercise | M | 3.30 | 25,422 | 83,799 | 115,230 | |
Jun 08 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Sell | S | 6.03 | 25,422 | 153,290 | 0 | 25.4 K to 0 (-100.00 %) |
Jun 08 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Buy | M | 3.30 | 25,422 | 83,799 | 25,422 | 0 to 25.4 K |
Jun 07 2017 | QURE | uniQure N.V. | Zelenkofske Steven | Chief Medical Offic ... | Grant | A | 0.00 | 175,000 | 0 | 175,000 | 0 to 175 K |
May 10 2017 | QURE | uniQure N.V. | Kapusta Matthew C | CEO, CFO, Managing ... | Option Exercise | A | 0.00 | 175,000 | 0 | 350,000 | |
May 10 2017 | QURE | uniQure N.V. | Kapusta Matthew C | CEO, CFO, Managing ... | Option Exercise | A | 6.22 | 175,000 | 1,088,500 | 175,000 | |
Mar 03 2017 | QURE | uniQure N.V. | Kapusta Matthew C | CEO, CFO, Managing ... | Option Exercise | A | 0.00 | 162,500 | 0 | 247,124 | |
Jan 31 2017 | QURE | uniQure N.V. | Keson-Brookes Maiken | General Counsel | Option Exercise | A | 0.00 | 43,250 | 0 | 43,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Keson-Brookes Maiken | General Counsel | Option Exercise | A | 5.37 | 43,250 | 232,253 | 43,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Garen Jonathan | Chief Business Offi ... | Option Exercise | A | 0.00 | 43,250 | 0 | 43,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Garen Jonathan | Chief Business Offi ... | Option Exercise | A | 5.37 | 43,250 | 232,253 | 43,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Cantor Maria E | SVP, Investor Relat ... | Option Exercise | A | 0.00 | 43,250 | 0 | 43,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Cantor Maria E | SVP, Investor Relat ... | Option Exercise | A | 5.37 | 43,250 | 232,253 | 43,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Option Exercise | A | 0.00 | 43,250 | 0 | 43,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Option Exercise | A | 5.37 | 43,250 | 232,253 | 43,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Option Exercise | A | 0.00 | 43,250 | 0 | 55,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Petry Harald | Chief Scientific Of ... | Option Exercise | A | 5.37 | 43,250 | 232,253 | 43,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Meyer Christian | Chief Medical Offic ... | Option Exercise | A | 0.00 | 43,250 | 0 | 55,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Meyer Christian | Chief Medical Offic ... | Option Exercise | A | 5.37 | 43,250 | 232,253 | 43,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Kapusta Matthew C | CEO, CFO, Managing ... | Option Exercise | A | 0.00 | 162,500 | 0 | 247,124 | |
Jan 31 2017 | QURE | uniQure N.V. | van Deventer Sander | Director | Option Exercise | A | 0.00 | 11,000 | 0 | 16,000 | |
Jan 31 2017 | QURE | uniQure N.V. | van Deventer Sander | Director | Option Exercise | A | 5.37 | 11,000 | 59,070 | 11,000 | |
Jan 31 2017 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Option Exercise | A | 0.00 | 11,000 | 0 | 16,000 | |
Jan 31 2017 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Option Exercise | A | 5.37 | 11,000 | 59,070 | 11,000 | |
Jan 31 2017 | QURE | uniQure N.V. | SCHAFFER DAVID | Director | Option Exercise | A | 0.00 | 11,000 | 0 | 16,000 | |
Jan 31 2017 | QURE | uniQure N.V. | SCHAFFER DAVID | Director | Option Exercise | A | 5.37 | 11,000 | 59,070 | 11,000 | |
Jan 31 2017 | QURE | uniQure N.V. | Lewis William | Director | Option Exercise | A | 0.00 | 11,000 | 0 | 16,000 | |
Jan 31 2017 | QURE | uniQure N.V. | Lewis William | Director | Option Exercise | A | 5.37 | 11,000 | 59,070 | 11,000 | |
Jan 31 2017 | QURE | uniQure N.V. | Kaye Jack | Director | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
Jan 31 2017 | QURE | uniQure N.V. | Kaye Jack | Director | Option Exercise | A | 5.37 | 11,000 | 59,070 | 11,000 | |
Jan 31 2017 | QURE | uniQure N.V. | Astley-Sparke Philip | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 30,000 | |
Jan 31 2017 | QURE | uniQure N.V. | Astley-Sparke Philip | Director | Option Exercise | A | 5.37 | 25,000 | 134,250 | 25,000 |